Advertisement
Screener

Axogen, Inc. (AXGN) Business Acquisition, Pro Forma Net Income (Loss)

3.2 / 5 stars · 63/98 Roast Me

Axogen, Inc. Business Acquisition, Pro Forma Net Income (Loss)

Axogen, Inc. (AXGN) reported Business Acquisition, Pro Forma Net Income (Loss) of -$8.61 million for the 12-month period ending 2011-12-31, per its 10-K/A filed 2013-08-07.

Discontinued › Expense Statement › Operating Expenses

us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2013-08-07

  • Axogen, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2011-12-31 was -$2.14M.
  • Axogen, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2011-09-30 was -$3.03M.
  • Axogen, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2011-06-30 was -$2.28M.
  • Axogen, Inc. business acquisition, pro forma net income (loss) for fiscal 2011 was -$8.61M.
Period endBusiness Acquisition, Pro Forma Net Income (Loss) 3 monthBusiness Acquisition, Pro Forma Net Income (Loss) 6 monthBusiness Acquisition, Pro Forma Net Income (Loss) 9 monthBusiness Acquisition, Pro Forma Net Income (Loss) 12 month
2011-12-31-$2.14M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-08-07
-$5.17M
derived: sum of 2 quarters · filed 2013-08-07
-$7.44M
derived: sum of 3 quarters · filed 2013-08-07
-$8.61M
10-K/A · filed 2013-08-07
2011-09-30-$3.03M
10-Q · filed 2012-11-06
-$5.31M
derived: sum of 2 quarters · filed 2012-11-06
-$6.47M
10-Q · filed 2012-11-06
2011-06-30-$2.28M
10-Q · filed 2012-08-14
-$3.46M
10-Q · filed 2012-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
BIOLIFE SOLUTIONS INC (BLFS)United States$1.887B23.80
TransMedics Group, Inc. (TMDX)United States$2.911B15.17
CONMED Corp (CNMD)United States$1.353B26.72
Ceribell, Inc. (CBLL)United States$0.916B-11.27
LivaNova PLC (LIVN)$4.158B24.01
Integer Holdings Corp (ITGR)United States$4.289B25.17
CapsoVision, Inc (CV)United States$0.310B-12.68
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53